Biocon-Serum Combine Forces, mRNA Opportunities On Radar

Investments In Vaccine Supply Chain Likely

 
• By Anju Ghangurde and Vibha Ravi
  
KMS and Adar
Serum Institute, Biocon Biologics Form Powerful Alliance • Source: Company
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip